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The risk of congen ital anomal ies in children of diabetic mothers is three to four times 
that in offspring of non-diabetic mothers. The exact mechanisms of these birth 
defects are not known. Of the several factors suggested to contribute to embryonic 
maldevelopment in diabetic pregnancy, the formation of reactive oxygen species 
(ROS) and subsequent disturbances to cel lar defenses appears to be a p lausible  
hypothesis. Antioxidants have been reported to rescue the embryos from being 
malformed in animal experiments . This study was aimed to determine if the ideal 
antioxidant l ipoic acid would ameliorate the embryos from maternal diabetes-induced 
anomalies.  
Method: 
Female Wistar rats (200-250 gm) were assigned to flve different treatment groups. 
Non-treated control rats, streptozotocin (STZ) (60 mglkg)-induced diabetes mellitus, 
STZ diabetic rats treated with lipoic acid (STZ+LA), l ipoic acid  and Tris buffer 
treated rats (LA control) ,  and Tris buffer alone treated rats. LA control and STZ+LA 
groups were treated with dai ly intraperitoneal injection of 20 mglkg LA from GD 6 
through GD 19. Morphological and skeletal mal formations of  the embryos were 
recorded. 
Results: 
D iabetic rats showed a significant incidence of resorption, growth retardation and 
malformation of fetuses. Lipoic acid and Tris buffer treatments showed no sign ificant 
d ifferences when compared with non-treated control data. Diabetic rats supplemented 
with l ipoic acid had a s ignificant decrease in fetal resorption/death, and improvement 
in fetal body weight .  Lipoic also sign ificantly reduced the incidence of various 
external and skeletal mal formations in the diabetic group. 
Conclusion: 
Lipoic acid exerts a potent protective effect against diabetes-related resorption, 
intrauterine growth retardation and malformations. Prospective studies should aim at 
evaluating the exact mechanism by which LA acts to rescue embryos of  growth 
retardation and malformations in this model . 
. .  
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basicranial  bones are hypoplastic in B, C. Also note that supplementation with LA 
improves the bone development (D) .  Mn = M andible, Zy =Zygoma, Eth = Ethmoyid, 
Ps = Presphenoid, Bs =Bas isphenoid, Bo = Basioccipital, Ex = Exooccipi ta l ,  So = 
Supraoccipi ta l . 
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Figure 11. Lateral view o f  the skulls of rat fetuses of day 20 of gestation. 
A:  Non -treated contro l .  B, C: STZ group, D: STZ + LA group. Note that the various 
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sternebrae. A: Control showing 6 sternebra with seven sternal ribs. B, C: STZ group 
showing hemi and double  hemi sternebrae (arrow in B, C) .  Also note that in C, there 
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are 6 sternal ribs on the right and 8 on the left. Costal cartilages 1 and 2 are fused in 
this fetus. Also note the reduction in the ossified length of the clavicles in B, C. 
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number of sternebrae (D). 
Figure 1 7. Dorsal view of skeletons of non-treated control (A) and diabetic group 
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sacral but not of the coccygeal segment of the STZ group (C) .  
Figure 19. Forelimbs of rat fetuses of day 20 of gestation. A: Non-treated control. 
Observe hypoplasia of the bones of the STZ group fetus (B). Treatment with lipoic 
acid improved the ossification of the bones of the STZ group (C). 
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Figure 20. Hip bones of rat fetuses of day 20 of gestation. A: Non-treated control. 
ote the size of the ilium, ischium, pubis, acetabulum and obturator foramen. 
Observe the smaller size of all these parts in the hip bone of the STZ group fetus (B). 
Figure 21. Hindlimb skeletons of rat fetuses of day 20 of gestation. 
A: Non - treated control. Observe that femur, tibia, and fibula are much smaller in 
the STZ group (B). The metatarsals and phalanges are both hypoplastic in (B). 
Figure 2 2. Derivatives of the neural crest. The crest cells originate during 
neurulation from the dorsolateral edges of the neural folds, migrate peripherally and 




DIabetes is one of the oldest diseases known to human kInd. It was first recorded in the 
ancient Egyptian papyrus as early as 1 550 BC. (Pickup and Willian1s, 1 997). It is called 
in Indian literature Madhu (sweet) Meh (rain) recorded as early as the 5th to 6th century 
AD (Sharma et aL, 1 993) .  The term "diabetes mellitus" (DM), was first used in the late 
1 8th century by Jolm Rollo and others, an allusion to the honeyed taste of urine (Pickup 
and Williams 1 997).  
Diabetes is a metabolic disorder characterized by chronic hyperglycemia, exceSSIVe 
urination (polyuria), profound thirst (polydypsia), polyphagia and weight loss resulting 
from defects in insulin secretion, insulin action or both (Ellenberg and Rifkin, 1 983).  
Diabetes affects 6 percent of total population or approximately 16 million people in USA 
alone (Davidson, 1 99 1 ) . It is considered a leading risk factor for heart attack and stroke, 
the leading cause of blindness, kidney diseases and gangrene (death of tissue due to poor 
blood circulation) resulting in amputation of lower limbs of patients with long-term, 
poorly controlled diabetes. 
1 .2 Classification of diabetes mellitus 
The classification of diabetes mellitus has been recently revised and it is classified on the 
basis of etiology, natural history and clinical presentation of the disorder (The Expert 
Committee Report, 1 997).  The most common types of diabetes are insulin-dependent 
diabetes mel l itus (IDOM) or type I, non-insulin-dependent diabetes mell itus (NIDOM) 
or type II ,  and gestational d iabetes mel l itus (GOM). 
Insulin-dependent diabetes mellitus (100M) is caused by the autoimmune destruction 
of tIle 0-cells of the I lets of Langerhans which leads to l i t t le or no insul in secret ion . [t lS 
characterized cl inically by hyperglycemia and ketoacidosis which are the biochemical 
hallmarks of IDDM. The insulin-dependent diabetes mell i tus affects mostly the young 
people. However, at least 1 0% of diabetic patients aged over 65 years are insulin 
dependent (Pickup and Wil l iams, 1 997). Insul in-dependent d iabetes mel l i tus patients 
depend on insulin throughout their l ives to manage the diabetes condi tion. 
Non-insulin-dependent diabetes mellitus (NIOOM) IS a metabo l i c  di sorder 
characterized by an inabi l i ty to util ize glucose in the presence of insul in .  This disease is 
due to the combinations of insulin resistance and insul in deficiency. It is the most 
prevalent type of diabetes mell itus and affects about 85% of the diabetic popUlation. 
The b lood i nsulin levels remain high enough to prevent excessive l ipolysis and 
spontaneous ketoacidosis (Pickup and Wil l iams, 1 997).  I t  i s  d iagnosed mostly after 40 
years of  age and in people who are overweight and inactive. 
Gestational diabetes mellitus (GOM) is  defined as glucose intolerance first recognized 
during pregnancy (Metzger and Coustan, 1 998) .  Approximately 2% to 5% of all 
pregnancies are compl icated by GOM and the prevalence appears to depend on the 
popUlation s tudied .  This type can be managed with d ietary restriction and exercise 
alone, although up to 20% wi l l  require insul in injections (Burrow and Duffy, 1 999). 
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1.3 Diabetes and pregnancy 
1.3.1 Epidemiology 
Diabetes during pregnancy has been recognized as a medical problem for more than a 
century. During the 19th and early 20th centuries the major concern was for the mother­
to-be, \ ho faced a high risk of death from diabetes during pregnancy. As early as in 
1 882, Duncan wrote about the threat to the fetus during diabetic pregnancy: " Pregnancy 
is very l iable to be interrupted in its course; and probably always by the death of the 
fetus" (Duncan, 1 882) .  In a later review, the fetal mortality rate was noted to be between 
27 to 53% in different studies (Susssman and Matschinsky, 1 988) .  In 1 93 7  Prisci l la 
White brought into notice that deaths in  neonates of diabetic mothers were largely due to 
congenital defects (Whi te, 1 937) .  In a more recent study from the Josline Diabetes 
Center, 58% of the perinatal deaths in infants of diabetIc mothers were attnbuted to 
mal fonnations (Greene, 1 999). In 1 952, White reported a malfonnation rate of 80 % 
compared to the expected 1 . 8% (White, 1 952) .  A malfonnation rate threefold the 
nonnal (6 .4% vs. 2 . 1 %) was reported in a large material some ten years later (Molsted­
Pedersen et a1. , 1 964). 
Today, about 65 years after White's first report, the possib i li ties for diabet ic patients to 
achieve c lose to normal metabolic control are much greater. Yet there is an increased 
risk for a type 1 diabetic mother to have a chi ld with major mal fonnations than for non­
diabetic mother. Recent studies report the incidence of malformations in type 1 diabetes 
to be in the range of 4- 1 0%, which is about two- to fourfold the nonnal Incidence 
(Casson et aI . ,  1 997; Gunton et aI . ,  2000). The frequency of congenital mal formations 
among children of diabetic mothers has decreased during the last century but sti l l  
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remains substantial ly higher than that in non-diabetic pregnancy despite tight glycemic 
contro l .  
The dominating opinion has been that only pre-gestation diabetes i s  associated with an 
lllcreased nsk for fetal malfonnations (Chung and Myrianthopou los, 1975). Recent 
studies however report that the incidence of major mal fonnations is increased also 
when diabetes is first detected during pregnancy (Janssen et aI . ,  1 996; Schaefer et aI . ,  
1 997; Kousseff, 1 999). Inc luded in this group are, apart from women with GDM, also 
number of women with latent diabetes and women with not previously diagnosed type 2 
diabetes. Offspring of type 2 diabetic women show malfom1ation rates in the same 
magnitude, or even higher as offspring of type 1 diabetic women (Towner et a! . ,  1 995; 
Brydon et a!., 2000). Moreover, the pattern of mal fonnations in type 2 and gestational 
diabetes resembles the pattern of type 1 diabetes-induced mal forn1ations (Schaefer et a1., 
2000). The rate of perinatal deaths is also high in offspring of type 2 diabetic mothers, 
mainly due to late fetal death (Cundy et aI . ,  2000). However, the pregnant type 2 
diabetic women are o lder and more obese than pregnant non-diabetic women, which 
may contribute to impaired fetal outcome since age and weight are factors that may also 
affect perinatal morbidity and mortality rates. Overal l ,  these studies indicate than not 
only pre-gestational maternal type 1 diabetes but also type 2 and perhaps gestational 
diabetes can induce fetal malformations. The malformation rate in type 2 diabetic 
pregnancy and GDM is important to consider, taking into account that type 2 diabetes 
was estimated to constitute 8 %, and GDM as much as 88 % of diabetic pregnancies in  
the United S tates during 1988 (Engelgau e t  a I . ,  1995)  . 
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1.3.2Malformation occurring in diabetic pregnancy 
Maternal diabetes during gestation has serious implications for the maternal-fetal pair. 
Women with gestational diabetes (GD) have the risk of recurrence of (GD) during future 
gestatIOns, high risk for the future development of type 2 diabetes, cesarean section, 
metabolic complications stillbirths, hypoglycemia, ketoacidosis, hypertension and 
respiratory complication. Also there is a threefold increase in neonatal macrosomia in 
comparison to that of the control population (Burrow and Duffy, 1 999). It also gives rise 
to high incidence of abortion, congenital malformations and growth retardation, 
compared to that of the non-diabetic population (Kalter, 1 987; Padmanabhan and Al­
Zuhair, 1 988) .  Congenital malformations which are considered the major cause of infant 
mortality and morbidity, have been reported to occur about three times as often in infants 
of diabetic mothers (IDM) as in normal (Kucera, 1 97 1 ) .  
The organs most often affected in offspring of diabetic mothers are the central nervous 
system and the heart (Chung and Myrianthopoulos, 1 975' Soler et a1., 1 976; Deuchar, 
1 977; Khoury et al., 1 989; Ferencz et al., 1 990; Martinez-Frias, 1 994). The 
malformations with highest relative risks in diabetic pregnancy are spinal anomalies (e.g. 
the caudal regression syndrome), laterality defects and gross skeletal anomalies (Kucera, 
1 97 1 ; Deuchar, 1 977; Martinez-Frias, 1 994; Splitt et al., 1 999). Apart from gross 
morphological abnormalities, maternal diabetes has been suggested to induce more 
subtle long-term effects on the central nervous system. For instance, the metabolic 
control in the third trimester has been reported to correlate with the behavior of neonates 
and with mental development of two- to five-year olds (Rizzo et al., 1 990). Despite 
good glycemic control during gestation, one year old children of diabetic mothers 
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showed lower mental and psychomotor scores than controls (Hod et al . ,  1999). Thus, 
maternal diabetes can speci fical ly cause gross morpho logical abnonnalities in some 
organ systems and probably also subt le  functional eNS-defects. 
1.3.3 \Vhen are the malformation induced in diabetic pregnancy? 
KnO\ ledge regarding which organs are affected by mal fonnations in diabetic pregnancy 
combined w ith knowledge on the embryological development of these organs yielded 
the conclusion that these malformations are induced before the seventh week of gestation 
(Mi l ls  et a l . ,  1979). In vivo studies on d iabetic pregnant rats have shown that timed 
interruption of insul in therapy during day 6-10, i.e. during organogenesis, cause 
malfonnations (Eriksson et a l . ,  1989). However at least in  rodents, a diabetic 
environment affects embryonic development of pre-implantat ion rat embryos III "/1'0 
(Ornoy and Zusman, 1991). Moreover, after gonadotropin stimulat ion diabetic mice had 
fewer oocytes in the late stage of maturation compared to contro l  mice (Diamond and 
Moley, 1 993) .  Maternal diabetes and high glucose i n  vitro induced apoptosis in mouse 
blastocyts (Moley et al . ,  1998) and increased the expression of the pro-apoptotic protein 
Bax. These studies show that malfonnations can be induced by hyperglycemia around 
day 6-10 in rats but the developmental effects of high glucose/ maternal diabetes can be 
seen even in the pre-implantation embryos, suggesting a continuous vulnerab i li ty to a 
hyperglycemic  environment during early pregnancy rather than a spec ific  time point. 
However, the end-gestational morphological outcome of these very early alterations is 
unknown. 
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1.4 Teratogenic effect of diabetes in animal models 
Pathogenesis  of fetal malfonnations in diabetic pregnancy IS multifactoriaL 
Hyperglycemia during gestation is considered the single most common risk factor for 
women in al l  reproduc t ive age groups which cause pregnancy compl ications. There is a 
s ignificant interrelationship between embryonic mal formation, resorption, and maternal 
serum glucose concentrat ion (Styrud et al . ,  1 995; Rose et al . ,  1 988) .  It is also one of the 
metabolic parameters that could be involved in a l l  abnormalities in vitro models 
(Cockroft, 1 984). Reece found that hyperglycemia i nduced malformations in a dose­
related fashion. A 20% malformation rate was induced at glucose levels twice normal, 
an almost 50% malformation rate was induced when concentrations were increased 
fourfold and virtual ly a 1 00% rate was induced at glucose levels of 950 mgldl (Reece et 
al. 1 985) .  Eriksson in  1982 reported that diabetes i n  the pregnant rat decreased fetal 
weight and caused retardation of the skeletal maturation (Eriksson et a l . ,  1982). How 
exactly maternal hyperglycemia leads to fetal malformation is not known. Postulated 
theories ( Reece and H omko, 2000) include damage to the developing yolk  sac (Pinter et 
ai, 1 986; Reece et al . ,  1 989), deficiency states in membrane l ipids such as arachidonic 
acid or myoinositol  (Khandelwal et al . ,  1995 ; Reece et a l . ,  1 997), the l iberation of free 
oxygen radicals (Eriksson et a l . ,  1 99 1 ;  Eriksson and Borg, 1 993), and a disruption in  
signal transduction (Hod, 1 996). 
Hypoglycemia of even relatively short periods of t ime had also teratogenic effect in 
animal models (Smoak and sadler, 1990; Buchanan, 1 986) .  About 50% of the normal 
glucose concentration w as also found to be teratogenic  but not growth inhibi tory while  
30%-40% of  normal maternal glucose concentration was lethal to  the embryo in vitro 
(Sadler and Hunter, 19 87 ) . Somatomedin inhibitors found in high concentrations in 
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streptozotocin-induced diabetes are considered as possible teratogen. Sad ler et a! ., 
( 19 86)  using an embryo culture model found that low-molecu lar-weight fraction of  
somatomedin inhibitors were associated with an increased incidence o f  malfomlation 
and impaired growth. It has been shown in studies of  embryos in cu l ture that the ketone 
body at hIgh concentrat ions a lso causes embryonic malformations (Horton and adler, 
19 83 ;  Eriksson, 19 88) .  Diabetes also reported to have genotoxic e ffect in vivo in 
transgenic animal models .  Lee et ai. ,  199 5 observed a two-fold i ncrease in  the 
mutational frequency of the lac I trans gene in fetuses of diabetic environment compared 
with those in normog1ycemic condition.  Maternal diabetes or high glucose levels were 
found to d isturb the synthesis  of extracel lular matrix (ECM) which modulate the cel l-to­
cel l -matrix interactions (Cagl iero et a I . ,  199 3) .  
1 .5 Oxidative stress 
Oxidative stress is defined as the state of imbalance bet'vveen the production o f  free 
radicals and antioxidant defenses leading to potentia l  t issue damage (Hal l iwel l ,  199 5 ;  
Bulge and Helton, 199 8) .  Thi s  state results i n  an excess of  free radicals which can react 
with cel lu lar l ipids proteins and nuc leic acids, leading to local injury and ult imately 
organ dysfunction. Lipids are probably the most vulnerable biomolecul es susceptible to 
free radical attack. 
1 .6 Oxygen free radicals 
Free radicals affect virtually all aspects of biologic existence by reaction with and 
modificat ion of  structural,  metabolic, and genetic material . They are major factors 
impl icated in over 80 different diseases and health problems, including heart di sease, 
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cancer, diabetes, cataracts, macular degeneration, Alzheimer's, varicose veins, capi l lary 
fragi li ty, inflammatory diseases etc (Sosin and Jacobs, 1 998). Oxygen free radicals are 
defined as any species that contains one or more unpaired electrons (Gutteridge and 
Hal l iwel, 1 994) .  Free radicals arise from radiation, environmental chemicals, cigarette 
smoke and vanous other environmental sources. In addition to that, mitochondrial 
respiration is  considered the major intracel lu lar source of oxygen radicals (Chance et al ., 
1 979). Other potential sources are phagocytic cel ls such as neutrophiles, monocytes and 
macrophages. They use oxygen radicals as a part of their attack against invading micro­
organisms (Babior, 1 992). Auto oxidation of  biological molecules such as lipids, 
proteins, carbohydrates, DNA and RNA may account for a fairly signi ficant source of 
oxygen radical production in vivo (Rice-Evans et al . ,  1 995).  S ince most molecules 
present in l iving organisms do not have unpaired electrons, any free radical will most 
l ikely react with non radicals, generating new free radicals. 
Oxygen free radicals affect cel l s  by three mechanisms (Koppenol ,  1994). First, they 
initiate a single reaction. Second, the oxygen radicals may start a chain reaction that 
generates more radicals as a byproduct. The third mechanism - the branching reaction­
is the most destructive in which the oxygen radical generates more free radicals as in the 
chain- type reaction. These radicals continue to initiate further reaction, each with their 
own radical byproducts. This mechanism can continue until cel l function stops. 
There are many types of free radicals that attack tissues such as superox ide radical, 
hydroxyl radical, hypochlorous acid, peroxyl radical , and single oxygen. The hydroxyl 
radical is the most reactive oxygen species that attacks and oxidizes all bio logical 
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molecu les as soon as it comes into contact with them (Rice-Evans et a l . ,  1 995; . 
Gutteridge and Hal liwel, 1 994). 
1.7 Cellular defences against free radical damage 
There IS a s 'stem of  biochemical defenses that protect organisms from the free radical 
damage in an oxidizing environment . These biochemical defenses include both low 
molecular weight free radical scavengers and complex enzyme systems. Low molecular 
weight free radical scavengers include l ipid soluble antioxidants (e g. Vitamin E, 
ascorbate and �-Carotene) that reducing lipophi l ic free radical species to less toxic form. 
Cytop lasmic antioxidants include tripeptide, glutathione etc. Enzymatic free radical 
scavengers include catalase, peroxidase etc. (Freeman and Crapo, 1 982) .  
1.8 Antioxidants 
Antioxidants are a group of  compounds that are produced by the body and also those that 
occur natura l ly in many foods. Packer and Tri tchler ( 1 996) defined antioxidant as a 
"metabolic intermediate that protects biological tissues from free radical damage, which 
is able  to be recycled or regenerated by biological reductants", while Hal l iwell ( 1 995 ) 
defined an antioxidant as "any substance that when present at low concentrations 
compared to those of an oxidisable substrate significantly delays or inhibits oxidation of  
this substrate". An antioxidant works by stopping the chain reaction caused by free 
radicals by either removing free oxygen radicals, preventing their formation or by 
repairing the damage that has been caused in cel l structure (Hal l iwel l ,  1 99 1 ) .  
Antioxidant therapy is widely used now to scavenge the free radicals that are considered 
the main factor in most di sease. Antioxidant supplementation had advantageously been 
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used to support anti-hypertensive therapy in diabeti c patients (Ceriel lo et at . ,  1 99 1 ) . 
Eriksson and colleagues (Eriksson and Siman, 1 996; Siman and Eriksson, 1 997a; Siman 
and Eriksson, 1 997b) used butylated hydroxytoluene, vitamin E and vitamin C to prevent 
diabetes-induced malfom1ations in the rat. 
1.9 Alpha lipoic acid 
Alpha lipoic acid, also known as Thioctic Acid is a powerful antioxidant that works 
double duty. It prevents free radical damage in every cell and in every organ. Alpha 
lipoic acid was first known as a fundamental chemical required for the normal growth of 
bacteri a as early the late 1 930s but it was not isolated unti l 1 95 1  from l iver tissue by 
Reed ( 1 95 1 )  It was named Lipoic acid because it could be dissolved in l ip ids, however it 
\vas named also Thioctic acid because i t  contains two sulfer atoms (S = thion in Greek) 
and eight (octo in Greek) carbon atoms (Berkson, 1 998) .  Alpha lipoic acid is produced 
natural ly in the body and also can be found in the leaves of plants contain ing 
mitochondria and in non-photosynthetic plant tissues, such as potatoes, spinach, 
broccoli ,  tomatoes, carrots, yams, and sweet potatoes. It is the only antioxidant which is 
both fat and water soluble (Sosin and Jacobs, 1 998). A lpha l ipoic acid in the diet can be 
transported to the tissues and taken up by cel ls where it is converted in a large 
proportion to dihydro lipoic acid (DHLA) (Figure 1 )  which can regenerate other 
antiox idants, such as vitamin C and vitamin E, and can also convert back to A lpha l ipoic 
acid (Cakatay et a1., 2000). 
An ideal antioxidant m ust fulfil l  a set of criteria such as specificity of free radical 
quenching, metal chelating activity, interaction with other antioxidants, effect on gene 
expression, absorption and bioavailabi lity, concentration in tissues, cell and extracel lular 
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Figure 1 .  Chemical structure of a-l ipoic acid. Alpha 
lipoic acid i s  converted into dihydrolipoic acid. 
fluid, and location ( in aqueous or membrane or in both) (Paker et a l . ,  1 995).  Alpha lipoic 
acid is  fulfi l ls  a number of these cri teria and therefore it is  known as a universal 
antiox idant. Lipoic acid has been used widely in the treatment of several diseases such 
as Ischemia-reperfusion i nj ury , heavy metal poisoning, neurodegeneration, diabetes 
complicatlOns, cataract, HfY infection, and cigarette- smoke lI1duced pathologies ( Paker 
et al . ,  1 995) .  No animal or human studies have shown serious side effects of l ipoic acid.  
No evidence exists for i t  carcinogenic or teratogenic  effects. The only fatal effect 
reported relates to thi amine deficiency in the rat and this could be prevented by 
administration of thiamine before LA treatment (Gal, 1 965) .  The LD50 for rats i s  
reported to be 400-500mgfkg (paker et  a l . ,  1 995) .  
1. 10 Objectives: 
The main objectives of the present study were to : 
• Establ ish an experimental diabetic model and study the maternal and fetal 
compl ications. 
• Establ ish an effect ive dose of LA which wi l l  not affect survival of the embryos 
and cause minimal or no maternal toxici ty. 
• Study the effect o f  this  dose of LA on maternal-fetal pair. 
• To determine the protective effects i f  any, of  LA against maternal diabetes­
related malformations and growth retardation. 
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MATERIALS AND METHODS 
2. 1 Chemicals 
LIpoIC acid ( D L-6,8-Thioctic acid, Sigma T-5625 ), Streptozotocin (STZ, Sigma S-0 1 30) ,  
Altzann red-S (S igma, A 5533) ,  Alcian blue 8GX ( 19ma, A3 1 5 7 )  were obtained from 
igma Chemical St Louis, MO. 
2.2 Experimental animals 
Wister rats used in  this study were purchased from Harlan Olac, England and raised in 
our local faci l i ty. They were maintained at a temperature of 2 1 ±  1 °c and at relative 
humidity of 60-65%. Food and water were provided at libitum. Female Wistar rats 
\ eighing 200 to 250g on a 1 2 :  1 2  h l ight/dark cycle, were mated in smal l  groups with 
males in  the even mg. A spern1 posi t ive vaginal smear observed on the fol lowing 
mornmg was considered to indicate successful copUlation. Sperm-positive day was 
designated as day 0 of pregnancy. Pregnant animals were divided into 5 groups : 
1 .  Non-treated control group. 
2 .  Streptozotocin  (STZ) group. 
3. Tris buffer group. 
4 .  Lipoic acid ( LA)  + Tris buffer group. 
5. STZ + LA group. 
2.3 Induction of diabetes 
Diabetes was induced on gestation day (GD) 2 by a single intraperitoneal (JP) dose of 60 
mgfkg of body weight o f  STZ dissolved in ci trate buffer (pH 4 .5 ) .  A blood glucose level 
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of 200 mg/dJ or more estimated photometrically 24 hrs after STZ-injection was taken to 
indicate diabetes. 
2.4 Lipoic acid treatment 
LIPOIC aCId ( D L-6, -Thiocttc acid) IS insoluble In water (Budavan, 1 996) .  It was 
therefore disso lved in aOH ( 1  in Tris buffer). The pH was adjusted to 7.4 by addition 
of O . l N  Hel .  When animals were inj ected (IP) with 30 mg!kg of LA from GD3 through 
GD 1 9, a l l  embryos were found to be resorbed. Therefore, a single dose of 20mg!kg (IP) 
LA was injected dai ly starting GD6 and continued through GDI9. 
2.5 Measurement of blood glucose levels 
Every alternate day, b lood glucose estimations were made between 4-5 pm by using a 
One Touch I I  \& glucometer (L ife can, Jolmson and Johnson, U A) for each individual 
animal of all the groups . B lood samples for glucose measurements were obtained by a 
small incis ion with a steri le blade in the tai l t ip .  
2.6 Body weight and food and water consumption 
Body weight and food and water consumption were recorded dai ly from GD I through 
GD I 9. 
2 . 7  Collection of fetuses 
On day 20 of  pregnancy the animals were k i l led by excess ether anesthesia. Uterus was 
exposed by laprotomy and fetuses were collected. The resorption sites were counted. 
The fetuses were cleared of the membranes, rinsed in water and blotted dry. The fetal 
and p lacental weights were recorded. They were then fixed in 95% ethanol. 
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2.8 Embryo examination 
Embryos were observed with a dissecting stereomicroscope. They were then examined 
for visceral malformations according to Sterz and Lehmann ( 1 985) .  
2.9 Double staining 
Skeletons were stained according to Inouye's, ( 1 976)  method. The skin and adipose 
tissue were removed a few days after fi xation. The embryos were then placed in  acetone 
for one day to remove the fat .  A mixture of staining solutions was prepared from 0.3% 
alcian blue in  70% ethano l  and 0. 1 % al izarin red in 95% ethanol .  Embryos were stained 
in staining solution for 2 days at (3rC) and then placed in 1 % aqueous solution of KOH 
for 4 days . The specimens were cleared through 20%, 50% and 80% glycerin, and 
finally stored in 1 00% glycerin .  They were then observed with a dissecting 
stereomicroscope and the normal and abnormal skeletons were photographed. 
2.10 Statistical analysis 
Chi-Square test and Student t-test were performed using Mini Tab program. Criterion for 
s ignificance was set at P<0.05 .  
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RESULTS 
3 . 1  M aternal  effects 
dmln istrat ion of a single dose o f  STZ resu lted in diabetes characterized by 
hyperglycemia. A blood sugar level of  200mgldl or more observed 24 hrs after STZ 
treatment was regarded as diabetic condition. The blood sugar level in diabetic animals 
ranged from 3 75-500 mg/dl .  There was considerable dai ly fluctuation in sugar levels. 
Treatment with LA did not significantly affect the b lood sugar concentration of both 
diabetic and non-diabetic animals (Figure 2). The diabetic group registered lower body 
weight gain in comparison to the controls .  Supplementation with LA (20 mg/kg) was 
found to improve the body weight gain close to the levels of the controls but did not 
normalize the weights completely (Figure 3 ) .  The food and water consumption was 
significantly increased in the diabetic animals (Figures 4, 5) .  Treatment of the diabetic 
animals with LA reduced the food and water consumption but the reduction did not 
reach the l evels comparab le to the controls .  A simi lar treatment of non-diabetic ani mals 
did not have any effect on their food and water consumption. The diabetic animals were 
also found to pass a lot of urine as evidenced from their wet bedding. They were not as 
active as non-treated controls .  
3.2 Fet a l  effects : 
Resorption 
Administration of STZ (60mg/kg) on GD2 fo l lowed by LA (30mg/kg) on GD3 and 
continued through GD 1 9  was found to result in total embryonic resorption. Therefore, 
in subsequent experiments a lower dose of LA (20 mg/kg) was administered and the 
treatment was delayed unt i l  implantation was Initiated i . e. GD6 and continued through 
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Fig u re 2 .  Blood glucose levels in STZ-induced diabet ic rats during 
pregnancy. Observe that LA-treatment of diabetic rat has not brought 
down blood sugar levels significantly. 
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Figu re 3. Maternal weight in STZ-induced diabetes in the rat . 
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Figure s. Maternal water consumption in STZ-treated diabetes during 
pregnancy. Observe that LA-treatment of diabetic rats improves their 
water consumption. 
GD 1 9. This  resulted in good fetal viabil i ty. Table 1 indicates that treatment with either 
tris-buffer or LA had no s igni ficant effect (P>0.05) on embryonic resorption when 
compared with non-treated contro l group. Diabetes was found to cause m an ifold 
in rease in the embryonic resorption and death in comparison to the non-treated, bu ffer­
treated and LA-treated contro l groups. A l l  twenty embryos in two of the fourteen 
di abetic rats were found to have been resorbed . Supplementation with l ipoic acid 
substantia l ly reduced diabetes related embryonic resorption (Table 1 ) . 
Fetal weight 
1atemal diabetes also reduced significantly the fetal weight (Figure 6). For example the 
fetal body weight of  the STZ- treated group was about 50% less than that of  non-treated 
contro l (2 .20 ±0 .52 g vs 4 .0 1 ±0 .5  g P<0.05) .  The di fference in the mean weight is about 
1 . 30 g. On the other hand, when the variabi l i ty of the observations was consedered, the 
results indicated that the two populations had the same variabi l i ty (same variance) .  We 
also tested normality of the two samples. This test indicated that the weight of control 
fetuses were normally distributed whereas, the weight of STZ group fetuses were not 
c learly normally distributed (Student t-test) .  
I n trauterine growth retardation 
Intrauterine growth retardation (IUGR) was determined as reduction in fetal body 
weight. Those fetuses that weighted 1 Standard Deviation (SD) or 2SDs less than the 
mean of the non-treated controls were regarded as growth retarded. About 1 1  % of the 
non-treated control fetuses were at - l SD and another 6% at -2SD in body weight. 
A lmost 94% of  the diabetic group fetuses were at -2SD in weight and the remainder was 
at - l SD .  Treatment with the buffer or LA alone was found to cause a twofold increase in 
Table 1. Effect of  Lipoic Acid (LA) supplementation on fetoplacental development in STZ-induced diabetes 










STZ = Streptozotocin. 
LA = Lipoic Acid. 
Means = litter means. 
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74 7 1  
1 40 1 03 
54 50 
58 55  
83 75 
Resorption / dead fetal weight (g) Placental  weigh t (g) IUGR 
(%) (Litter Mean ± SD) (Litter mean ± SD) -SD (%) 
3 (4. 1 )  3 5 .6 ± 7 . 1 4  4 .8  ± 0.62 1 l .2 
37 (26.4) a 2 l .26 ± 4.68 c 7 .4  ± 1 . 59 6. 1 2  
4 (7 .4) 28 . 8 1  ± 7.08 4 .2 ± l . 0 1  37 .7  
3 (5 .2)  29. 1 5  ± 4 .25 4 .8  ± l . 00 6 .38 
8 (9 .6) b 25 .32  ± 7 .20 d 6 .32 ± 1 . 79 30.9 
IUGR = Intra Uterine Growth Retardation. Any fetus with a body weight less than 1 SD or 2 S D  of the non-treated control mean was regarded as growth retarded. 
a, c P< 0.05 when compared with not treated control .  
b, d P< 0 .05 when compared with STZ group, indicating the beneficial effect of LA in reduc ing the resorption/death rate and enhancing the fetal body weIght. 
Student t-test. 
* P< 0.05 when compared with non-treated contro l .  




5 .6  
93 .87 * 
1 l . 1  
1 0.6 
6 1 .9 * *  


fUGR at -2SD level. Supplementation of the diabetic rats with LA significantly reduced 
the incidence of fUGR. The various stat istical analyses indicated that there were no 
strong di fferences between the non-treated control and the buffer treated control groups 
or the LA group as far as the fetal and the placental weights were concerned. The 
al terat ion in placental weight due to buffer or LA treatment was marginal and not 
di fferent from the mean weight of control placentas . The comparison between the non­
treated group and STZ group placentas showed that the distribution of the placental 
weights of the STZ group was very spread, and most of the values were larger than the 
l argest value of  the non-treated group. This  i s  confirmed by the test of equali ty of the 
standard deviations of  the two variables .  The results showed that the equali ty of the 
variances was rej ected at 5% by Bartlett test. Supplementation of the diabetic animals 
with LA moderately reduced the placental weight which was sti l l  higher than that of the 
non-treated controls .  From these experiments it became c lear that LA substantial ly 
rescued rat embryos from maternal d iabetes-related resorption and fUGR (Tab le 1 ) . 
3.3 Morphological abnormalities 
Except perhaps for a low incidence of intrauterine growth retardation, the non­
treated control fetuses did not have any congenital anomalies. There was a high 
incidence of  malformations in the diabetic group (35 .2  %, p<O.05 Chi-Square test). 
Supplementation of diabetic rats with LA reduced the incidence of congenital 
malformations i n  the offspring to as low as 5%. Lipoic acid alone was found to have 
induced thin  eye l id in one of the 5 1  embryos. Most abnormalit ies of the diabetic group 
appeared to have affected the craniofacial region. There was a low incidence of central 
nervous system abnormalities in the diabetic group (Table 2) .  There were no CNS 
anomalies in LA group. The Tris bu ffer group had one fet us with occipital meningocele. 
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Table 2.  Effect of Li poic Acid ( LA) supplementation on preventing fetal malformations in STZ-induced 
diabetes in the rat . 
Type 
N o n-treated STZ * T risbuffer LA con tro l  
of m a l form ation n=36 0= 1 05 0=32 0=5 1 
Hydrocephaly 0 4 (3 . 8 )  0 0 
Exencephal ly 0 1 (0 . 9 5 )  0 0 
Occiptal Meningocele 0 7 (6.6) 1 (3 . 1 2) 0 
Holoprosencephal ly 0 
( cyclopia) 
0 0 0 
Spina bifida oculta 0 J (0 .95)  0 0 
Oblique facial  cleft 0 1 (0 .95)  0 0 
Exophthalmia (open eye) 0 3 (2 . 8 5 )  0 0 
Thin eye l id 0 1 2 ( 1 1 .4) 0 1 ( 1 .96) 
Low ear set (mic rot ia) 0 4 ( 3 . 8 )  0 0 
Gastroschisis 0 2 ( 1 . 9 )  0 0 
Maxil lary hypoplasia 0 1 0  (9 .5)  1 (3 . 1 2) 0 
Mandibular  Micrognathia 0 0 0 0 
Mandibular  agnathia 0 0 0 0 
Edema 0 1 (0 .95)  0 0 
* P < 0.05 when compared with non- treated control .  
* *  P <  0.05 when compared with STZ group, indicate that L A  rescue the embryos s ignificantly from diabetes- induced malformat iom. 
Chi-Square test . 










1 ( 1 .2) 
0 
0 
1 ( \ .2 )  
1 ( 1 .2)  
0 
The hydrocephaly fetuses o f  the diabetic group had a dome shaped head and distended 
cerebral ventricles. There was a single case o f  exencephaly in the STZ group. This fetus 
had unclosed neural tube and a large open defect of the skul l  vault (Figure 7C). The 
exposed bram ti ssues \ ere found to be hemorrhagic. This embryo was growth retarded 
and had excessive amn iotic fluid (polyhydroaminious). It had maxi l lary and mandibular 
hypoplasia and low-set microtia. There were 7 cases of  meningocele in the diabetic 
group. In al l  of  them the lesion was situated in the occipital region (Figure 8D) .  
Administration o f  LA appeared to prevent these anomalies completely as it was evident 
from the fact that there was no single such case in the LA+STZ group. There was a 
single case o f  holoprosencephaly in STZ+LA group. Thi s  fetus had a median eye, low 
and anteriorly set ears, a proboscis, astomia (absence of mouth cavity) and microcephaly 
(Figure 9C) .  There were two types of eye mal formations and both related to the eye l id .  
In exophthalmia (three cases in STZ group and two in LA+STZ group), the eyes 
remained open thus exposing the eyeballs to the abrasive effects of the amni otic fluid. 
There were several cases of  thin eye lid characterized by a transparent nature of the lids. 
There was a single case of oblique facial cleft in diabetic group characterized by the 
fai lure o f  union between lateral nasal process and the maxi l lary process (Figure 7B). 
This fetus also had the ear set low close to the trans-oral line. In control fetuses the ear 
is  situated above the trans-oral line (Figure 7 A). In the control fetuses, the tip of upper 
j aw is a l i tt le anterior to that of the lower j aw. Those cases in which the upper jaw was 
at level with or behind the tip of the lower jaw were regarded as maxi l lary hypoplasia. 
In mandibular hypoplasia the tip of  the lower j aw was far behind that of  the upper jaw.  
Smal l  j aws were associated with protruding tongue (Figures 7C, 8A). There were ten 
cases of  m axi l lary hypopl asia (9. 5%) in the diabetic group. There was one fetus in the 
d iabet ic group with edema of  the entire body (Figure 8B) .  There were two cases of 




gastroschisis one with exencephaly and one without (Figure 7C, D). Both belonged to 
the diabetic group. This anomaly was characterized by a large abdominal wall defect 
involving the umbi lical and infraumbil ical parts of the ventral abdominal wal l .  The liver 
and loops of the smal l intestine were found to be projecting external ly through this 
defect .  
3.4 S keletal  mal fo rmation s  
Skull defects 
The entire skul l  was examined after staining with al izarine red and alcian blue. In  the 
non-treated control fetuses, all the bones of the skull had developed very well  
appropriate for GD20 (Figure l OA; Figure 1 1 A; Table 3) .  The buffer and LA both had a 
low incidence of  hypoplasia of various bones and in  the STZ group only about 1 0-20% 
of the bones were found to have been normally developed. The remaining 80% were 
hypoplastic (Figure l OB ,  C; Figure l I B ,  C) .  Supplementation with LA rescued the bone 
hypoplasia to normal development in about 30% of cases (P<0.05 Chi-Square test) 
(Figure l I D). The ethmoid, presphenoid, basispheniod, basioccipital, and exoccipital 
bones were al l  well ossified in the control fetuses (Figure l OA).  Hypoplasia of the 
d ifferent bones of the base of the skul l  in diabetic group had resulted in reduction in the 
anteroposterior and transverse diameter of the sku l l  base. Supplemetation with LA 
substantially improved the size of the skull bones and as a resu lt, i t  increased the 
diameters from diabetes-induced hypoplasia (Figure l OB, C, D). Hypoplasia of the 
bones of the vault  of the skul l  had resulted in wide fontanel les in about 60% of the 
fetuses of the diabetic group. Supplementation with LA improved the ossification of the 
skul l  vault resulting i n  reduced the size of fontanel les significantly. The supra-occipital 
bones of non-treated control group had reached stage 4 of development (Ari yuki et aI . ,  
20 
Table 3 .  Effect of L i poic Acid ( LA) s u pple mentation on skull bones d evelo pment in STZ-induced d iabetes in the rat. 
Non-treated contro l  (%) STZ (%) B u ffer (%) 
n = 35 n = 45 n = 32 
Bones Nonrmally N o n r m a l l y  * N o n r m n l l y  I l ypoplastic Absent Hypoplastic A bsent  l J y poplat ic  
ossified ossified ossified 
Mandible  3 3  (94.3) 2 (5 .7) 0 6 ( 1 3 . 3 )  39 (86.6) 0 2 7  (84 .3)  5 ( 1 5 .6) 
P r e m a x i l l a  3 5 ( 1 00) 0 0 6 ( 1 3 . 3 )  3 9  (86.6) 0 27 (84 .3)  5 ( 1 5 . 6) 
I.y gomatic 3 5  ( 1 00) 0 0 6 ( 1 3 . 3 )  39 (86.6) 0 27 (84 .3)  5 ( 1 5 .6) 
Nasal  3 5 ( 1 00) 0 0 6 ( 1 3 . 3 )  3 9  (86.6) 0 27 (84 .3)  5 ( 1 5 .6) 
Frontal  3 5  ( 1 00) 0 0 6 ( 1 3 . 3 )  39 (86.6) 0 27 (84 .3)  5 ( 1 5 .6) 
Parietal 3 5  ( 1 00) 0 0 6 ( 1 3 .3)  39 (86.6) 0 27 (84.3)  5 ( 1 5 .6) 
I nter parietal  3 5 ( 1 00) 0 0 6 ( 1 3 . 3 )  3 9  (86.6) 0 27 (84 .3)  5 ( 1 5 .6) 
Supra- 3 5  ( 1 00) 
occipital  
0 0 6 ( 1 3 . 3 )  39 (86.6) 0 27 (84.3 )  5 ( 1 5 .6) 
Exoccipital  35 ( 1 00) 0 0 6 ( 1 3 . 3 )  39 (86.6) 1 (2 .2 )  27 (84 .3)  5 ( 1 5 .6) 
Tem pora l 3 5 ( 1 00) 0 0 6 ( 1 3 . 3) 39 (86.6) 0 27 (84 . 3 )  5 ( 1 5 .6) 
Tym p a n ic 35 ( 1 00) 
ring 
0 0 6 ( 1 3 . 3 )  3 7  (82.2)  2 (4.4) 3 1  (88.6) 1 (3 . 1 )  
( (yoid 34 (97. 1 )  0 1 (2 .8) 5 ( \ 1 . 1 )  3 7  (82.2) 3 (6.6) 26 (8 1 . 3 )  5 ( 1 5 .6) 
Ethmoid 3 5  ( 1 00) 0 0 6 ( 1 3 . 3 )  39 (86.6) 0 27 (84. 3 )  5 ( 1 5 .6)  
Presphenoid 3 5  ( 1 00) 0 0 6 ( 1 3 . 3 )  3 9  (86.6) 0 27 (84 . 3 )  5 ( 1 5 .6) 
Basisphenoid 3 5  ( 1 00) 0 0 6 ( 1 3 .3 )  39 (86.6) 0 27 (84. 3 )  5 ( 1 5 .6) 
lJasioccipital  35 ( 1 00) 0 0 8 ( 1 7 .7) 37  (82.2) 0 27 (84. 3 )  5 ( 1 5 . 6) 
Normal 0 0 wider 28 (62.2) 0 30 (93 .7) Wider Fontanelles 35  (1 00) 1 7 (37 .7) 2 (6.2) 
Meckel's 1 (2 .8) 20 (44.4) 2 (6.25) 
carti lage 
• P< 0.05 when compared with non-treated control .  
u P <  0 .05 when the reduction in hypoplasia is compared with t h e  frequency of hypop lasia o f  t h e  STz group. 
Chi-Square test. 
LA (%) STZ + LA (%) 
n = 45 n = 3 7  
Nonrmally Nonrmally * *  Absent H y poplastic A b� e n t  Hypop l astic ossified ossified 
0 43 (95 . 5 )  2 ( 4  4) 0 1 6 (43 .2)  21  (56 .7)  
0 43 (95 .5)  2 (4.4) 0 1 6  (43.2) 2 1 (56.7) 
0 43 (95.5)  2 (4 .4) 0 1 6  (43 .2)  2 1  (56.7) 
0 43 (95.5)  2 (4 .4) 0 1 6  (43 .2)  21  (56.7) 
0 43 (95.5) 2 (4 . 4) 0 1 6 (43.2) 2 1  (56.7) 
0 43 (95.5)  2 (4 .4) 0 1 6  (43.2) 21  (56.7) 
0 43 (95.5) 2 (4.4) 0 1 6  (43.2) 2 1  (56.7) 
0 43 (95 . 5 )  2 (4.4) 0 1 6  (43.2) 21 (56.7) 
0 43 (95 . 5 )  2 (4.4) 0 1 6  (43 .2)  2 1  (56.7) 
0 43 (95. 5 )  2 ( 4  4)  ( ) 1 6 (43.2)  2 1 (56.7) 
1 (3 . 1 )  4 5  ( 1 00) 0 0 1 6  (43 .2)  2 1  (56.7) 
0 43 (95.5) 2 (4 .4)  0 1 6 (43 .2)  19  (5 1 .4)  
0 43 (95 .5 )  2 (4 .4) 0 1 6 (43 .2)  2 1  (56.7) 
0 43 (95 .5)  2 (4 .4)  0 3 1  (83 . 7) 6 ( 1 6.2)  
0 43 (95.5)  2 (4 .4) 0 1 6  (43 .2)  2 1  (56.7) 
0 43 (95 . 5 )  2 (4 4) 0 1 6  (43 .2)  2 1  (56.7) 
0 45 ( 1 00) 0 0 3 1 (83 .7) Wider 6 (1 6 .2) 
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1 980). Maternal diabetic condition delayed the development of the supra-occipital bones 
and therefore about 50% of the STZ group embryos had only reached stage 2 of Ariyuki 
et al .  ( 1 980). Supplementation with LA of diabetic animals showed a sign ificant 
improvement in developmental stage of supra-occipital bones to stage 3 (Figure 1 2 ; 
Tab le 4 ;  P<0.05 Chi - quare test). 
All embryos of the non-treated control group had developed a mandible appropriate for 
GD 20. The Meckel's cart i lage had completely disappeared, except at the symphysis 
menti .  The presence of Meckel's carti lage in m andible of the STZ-treated group was 
prominent. In about 44% of STZ group fetuses, the entire Meckel's carti lage was found 
to be persistent. Supplementation with LA was found to almost half this incidence 
(Figure 1 3 , Table 3 ,  P<0.05 Chi-Square test). The hyoid bone was hypoplastic in the 
diabetic group fetuses (Figure 1 4A, B) .  Treatment with LA produced a modest rescue 
effect in about 30% o f  the embryos of the diabetic group (Figure 1 4C).  
Sternebrae bones 
The non-treated control fetuses had six sternebrae each. The c lavicle  was attached to 
the upper border of  the first sternebra (Figure 1 5  A ;  Table 5 ) .  The first seven ribs were 
attached at there ventral ends to the sternum via costal cart i lages. The seventh pair of 
ribs was attached to the sternum between sternebra 5 and 6. Only 20% (9/45)  of  the 
diabetic group fetuses had 6 ossified sternebrae and the rest had either 5 (36%) or less 
than 5 (44%) sternebrae each. Even those fetuses with the ful l  complement of the 
sternebrae had a variable number of hypoplastic sternebrae. Malposition of the 
sternebrae was characterized by a zigzag appearance of the two halves of the sternebrae. 
In a large number of cases the right and left primordia of the sternebrae remained 




Table 4. Effect of Lipoic Acid ( LA )  suppleme ntation on supra-occi pital bone developme n t  i n  STZ-in duced diabetes in 
the rat. 
N o n -t reated STZ ( % ) B u ffe r (0/0) LA (% ) Stage contro l  (0/0 ) n=45 n= 3 2  n= 45 n=3 5  
Stage 0 0 3 (6 .6) 0 0 
Stage 1 0 1 1  (24 .4) 0 0 
Stage 2 0 23 (5 l . 1 )  0 0 
Stage 3 0 8 ( 1 7 .7 )  0 0 
Stage 4 35  ( 1 00) 0 32 ( 1 00) 45 ( 1 00) 
* P< 0.05 when the advancement to developmental stage 3 or stage 4 is compared with the STZ group. 
Chi-Square test. 
- . 
LA + STZ (% ) 
n=3 7  
0 
2 (5 .4) 
0 
1 8 (45 .9) * 







Table 5. Effect of L i poic Acid ( LA) supplementa tio n  on sternal development in STZ-induced d iabetes in the rat. 
Non-trea ted STZ (% ) * Buffer (0/0) LA (% ) LA + STZ (% ) Sternebrae con trol (0/0) n=45 n = 32 n= 45 n=3 7  
n=35 
6 3 5  ( 1 00) 9 (20) 1 9  (59 .3 )  3 8  (84.4) 1 4  (37 .8 )  a 
5 0 1 6 (35 . 5 )  5 ( 1 5 .6)  4 ( 8 . 8 )  1 8  (48 .6)  a 
< 5  0 20 (44.4)  8 (25)  3 (6 .6 )  S ( l 3 . S ) a 
Hypoplasia 0 3 1  (68 .8 )  5 ( 1 5 .6)  6 ( 1 3 . 3 )  2 0  ( S4 .0S)  b 
M alposition 0 1 0 (22 .2)  3 (9 .3)  3 (6 .6 )  4 ( l 0 . 8 )  b 
Non-development 0 1 8  (40) 6 ( 1 8 . 75 )  4 (8 .8 )  1 0  (27) b 
I ncomp lete fusio n 0 1 8  (40) 4 ( 1 2 . S ) 2 (4.4 ) 8 (2 1 . 6 )  b 
-
* P< 0.05 when sternal anomalies of STZ group are compared with the non-treated control group. 
a P< 0.05 when compared with STZ group indicating that LA rescued the embryos from STZ-induced reduction in the number of sternebrae. 
b P> 0.05 when compared with STZ group indicating that LA does not rescued the embryos significantly from diabetes- induced mal formations. 
Chi-Square test 
unfused giving rise to double hemisternebrae (Figure 1 5B, C) .  Lipoic acid alone was 
found to induce a low frequency of sternal malformations. Supplementation with LA 
was found to substantially normalize the number of  sternebrae in the STZ group, bur it 
did not have a sign ificant effect on the frequency of  the hypoplasia, malpositioning, non­
de\ elopment and incomplete fusion (Figure 16) .  
Rib 
There were 1 3  pairs of  wel l  ossified ribs in the non-treated control embryos. Lumber 
ribs were regarded as supernumerary ribs when they were one half or more than one half 
the length of  the 1 3th thoracic rib .  Those that were less than half the 1 3th thoracic rib 
were counted as rudimentary lumber ribs. Except  in one case, al l  the non-treated control 
fetuses had 1 3  pairs of ribs. The fetuses of  STZ group had a very high incidence of 
lumbar ribs (P<O.05 ,  Chi-Square test; Figure 1 7B ,  D) and administration of LA to 
diabetic rats only moderately reduced this incidence (Table 6). However, LA appeared 
to improve the ossi fication of the ribs so that the hypoplasia observed in STZ group was 
seen m uch l ess frequency in the supplemented group (Figure 1 7D) .  There was one case 
of rib fusion and one case of interrupted ossification in the STZ group (Figure 1 7C).  
There were no such anomalies in the control or STZ+LA groups. 
Vertebral column 
Each vertebra consists of  an arch and a body. They are found in each vertebra 
except in the coccygeal vertebrae where only the bodies are found. In non-treated 
control fetuses, there were 7 well  ossified vertebrae in the cervical region, 1 3  in the 
thoracic region, 6 in the l umbar region, 5 -6 in the sacral region and a variable number of 
bodies in  the coccygeal region. The buffer group fetuses and LA alone group fetuses 






Table 6. Effect of Lipoic Acid (LA) s u pplementation on ribs development in STZ-induced d i abetes i n  the rat. 
N on-treated STZ (% ) Bu ffer (% ) LA (% ) STZ + LA (% ) control (% ) Ribs n=45 n= 32 0= 45 n=3 7  n=35 
Right Left Right Left Right Left Right Left R ight Left 
1 3  34 (97. 1 )  3 5  ( 1 00) 2 1  (46.6) 20 (44.4) 25  (78. 1 )  24 (75) 39 (86.6) 40 (88 .8 )  20 (54)  2 1  (56.7) 
J- Ilt 'It 1\'  14 ""  
1 4  1 (2 .9) 0 24 (53 .3)  25  (55 .5)  7 ( 2 1 .8)  8 (25)  6 ( 1 3 .3 )  5 ( 1 1 . 1 )  1 7  (45 .9) 1 6  (43 .2)  (Lumber) 
Fusion 0 0 1 (2 .2 )  0 0 0 0 0 0 0 
�-- -
* P< 0.05 when compared with corresponding non-treated controls. 
** P> 0.05 when compared with STZ group indicating that LA treatment did not significantly alter the frequency of 14 th ribs induced by l11atcl11al diabetes. 
Chi-Square test. 
showed absence and reduced number of vertebral bodies in the cervical region and 
hypoplasia of  almost 1 00% of the vertebral arches and bodies in al l  regions (Table 7) .  
There were 7 cases of  non-fused bodies in the thoracic region and one case in the lumbar 
region of the STZ group. Supplementation with LA had no beneficial effect on diabetes­
l I1duced hypoplasia in cerv ical region, but it reduced the incidence of hypoplasia of other 
vertebral regions (Figure 1 8) .  
Limb bones 
The non-treated controls showed good ossification of l imbs bones. The forel imb 
skeleton consisted o f  the clavicle, scapula, humerus, radius, ulna, 3-4 metacarpals and a 
variable  number of  phalanges (Figure 1 9A). The hindlimb skeleton consisted o f  the hip 
bone which comprises the i lium, pubis, and ischium (Figrue 20A; Table 8) and the 
femur, fibula, tibia, tarsal, 5 metatarsals and a variable number of phalanges (Figure 
2 1 A; Table  9).  There were about 94% of fetuses with 4 metacarpals and about 6% with 3 
metacarpals in non-treated control group. Fetuses of the diabetic animals showed a 
significant reduction in ossification of the l imb bones including the clavicles (Figure 1 5) .  
Fetuses of  the STZ+LA group showed a remarkable  recovery of ossification of  the 
forelimb and hindlimb bones from diabetes-induced hypoplasia. There were about 90% 
of fetuses with hypoplasia of the hipbone and the long bones of hindlimb in the diabetic 
group. Supplementation of diabetic animal with LA significantly helped in the recovery 
from diabetic induced hypoplasia of the 3 units of  the hip bone but the degree of the 
ossification was sti l l  not as good as that of the non-treated control group (Table 8) .  
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Table 7. Effect of Lipoic Acid (LA) supplementation o n  vertebrae develop ment in  STZ-induced diabetes in the rat. 
Non- treated STZ (%) Buffer (%) LA (%) STZ + LA (%) 
Number Control (%) 
Region 0= 35 
0= 45 n = 32 0= 45 0= 37 
Arches Bodies Arches Bodies Arches Bodies Arches Bodies Arches Bodies 
o (agenesis) 0 0 0 1 8 (40.0) 0 1 (3 . 1 ) 0 0 0 1 1  (29.7) 
1 -6 0 0 0 1 9  (42 .2) 0 26 ( 8 1 . 2) 0 34 (75 . 5 )  0 26 (70.2) 
Cervical 7 35 ( 1 00) 35  ( 1 00) 45 ( 1 00) 8 ( 1 7 .7 )  32 ( 1 00) 5 ( 1 5 .6) 45 ( 1 00) 1 1 (24.4 ) 3 7  ( 1 00) 0 
Hypoplastic 0 0 45 ( 1 00) 45 ( 1 00) 0 1 9  (59.3) 0 1 4 (3 1 . 1 ) 1 8  (64 .8) ] 8 (64.8) 
1 3  3 5  ( 1 00) 3 5  ( 1 00) 45 ( 1 00) 45 ( 1 00) 32 ( 1 00) 32 ( 1 00) 45 ( 1 00) 45 ( 1 00)  3 7  ( 1 00) 37 ( 1 00) 
Thoracic Hypoplastic 0 0 45 ( 1 00) 45 ( 1 00) 0 0 0 0 1 2  
(32 .4) * 1 2  (32.4) * 
Non-fused 0 0 0 7 ( 1 5 .5 )  0 0 0 0 0 0 
6 35 ( 1 00) 3 5  ( 1 00) 44 (97 .7) 44 (97.7) 32 ( 1 00) 32 ( 1 00) 45 ( 1 00) 45 ( 1 00 )  37 ( 1 00) 37 ( 1 00) 
7 0 0 1 (2 .2) 1 (2 .2) 0 0 0 0 0 0 
L u mbar Hypoplastic 0 0 45 ( 1 00) 45 ( 1 00) 0 0 0 0 1 0  (27.0) * 1 0  (27.0) * 
Non-fused 0 0 0 1 (2 .2) 0 0 0 0 0 0 
o (agenesis) 0 0 1 (2 .2) 0 0 0 0 0 0 0 
Sacral 5-6 35 ( 1 00) 35  ( 1 00) 44 (97.7) 45 ( 1 00) 32 ( 1 00) 32 ( 1 00) 45 ( 1 00) 45 ( 1 00 )  37 ( 1 00) 37 ( 1 00) 
o (agenesis) 35 ( 1 00) 0 45 ( 1 00) 1 (2 .2) 32 ( 1 00) 0 45 ( 1 00) 0 37 ( 1 00) 0 
Coccygeal 1 -3 0 33 (94 .3) 0 44 (97.7) 0 32 ( 1 00) 0 45 ( 1 00)  0 
37 ( 1 00) 
4 0 2 (5 .7) 0 0 0 0 0 0 0 0 ------ -- --















Table 8. Effect of Lipoic Acid (LA) supplementation o n  h i n d l i m b  bones development i n  STZ-induced d iabetes in  the rat. 
Non - treated control STZ Buffer LA STZ + LA 
(%) (%) (%) (%)  (%) 
Bones n = 35 n = 45 n = 32 n = 45 n = 37 
Normally Hypoplastic Normally Hypoplastic Normally Hypoplastic Normally Hypoplastic Normally Hypoplastic 
ossified Ossified ossified ossified ossified 
I l i u m  35  ( 1 00) a 5 ( 1 1 . 1 )  40 (88 .8)  30 (93 .8)  2 (6.25) 44 (97.7) 1 (2 .2)  1 7 (45 .9) 20 (54. 1 )  * 
I s c h i u m  35  ( 1 00) a 2 (4.4) 43 (95 . 5 )  30 (93 .8)  2 (6.25) 44 (97.7) 1 (2 .2)  1 6 (43 .2)  2 1  (56 .7)  * 
Pubis 35 ( 1 00) a 2 (4.4) 43 (95 .5 )  30 (93 .8)  2 (6.25 )  44  (97 .7) 1 (2 .2)  1 6  (43 .2) 21  (56 .7) * 
Fem u r  35  ( 1 00) a 4 (8 .8 )  4 1  (9 1 . 1 )  3 1  (96.9) 1 (3 . 1 )  45 ( 1 00) a 1 9  (5 1 . 3 )  1 8 (48 .6) * 
Tib ia 35 ( 1 00) a 4 (8 .8)  41  (9 l . 1 )  3 1  (96.9) 1 (3 . 1 )  45 ( 1 00) 0 1 9 (5 1 . 3 )  1 8 (48 .6) * 
Fibula  35 ( 1 00) a 4 (8 .8 )  4 1  (9 1 . 1 )  3 1  (96.9) 1 (3 . 1 )  45 ( 1 00) 0 1 9 (5 1 . 3 )  1 8 (48.6) * 
* P< 0.05 when compared with the corresponding of STZ group, indicating that LA administration significantly resc ued the embryos 
form diabetes related hypoplasia of the lower limb bones. 
Chi-Square test. 

Table 9. Effect of Lipoic Acid (LA) s u p p lementation o n  l imb skeleton develop ment i n  STZ-induced 
diabetes in  the rat. 
Non - treated STZ Buffer LA STZ + LA 
Bone N u mber control (% ) ( % ) (0/0) (% ) ( % ) 
n = 35 n =45 n = 32 n = 45 n = 3 7  
3 a 2 (5 . 7 )  3 3  (73 . 3 )  3 (9.4) 2 (4.4) 1 4  ( 3 7 . 8 )  
Metacarpals  4 a  3 3  (94 .2)  1 2  (26.7) 29 (90.6) 38  (84.4) 23 (62 .2)  
5 0 0 0 5 ( 1 1 . 1 )  0 
o (agenesis) 0 2 (4.4) 0 0 0 
3 0 1 0  (22 .2) 0 0 0 
Metatarsals 
4 35  ( 1 00)  3 3  (73 . 3 )  32 ( 1 00) 36 (80) 37 ( 1 00) 
5 0 0 0 9 (20) 0 
o (agenesis) 1 (2 .9)  2 (4.4) 2 (6 . 3 )  0 0 
Phalanges 1 - 5 b 2 1  (60) 4 1  (9 1 . 1 )  7 ( 1 2 . 8 )  3 1  (68 .9)  24 (64.9) 
(Forelimb) 
6 - 1 0  b 1 3  (37 . 1 )  3 (6.7) 23 (7 1 . 8)  1 4  (3 1 . 1 )  1 3  ( 3 5 . 1 )  
o (agenesis) c 3 (8 .6 )  30 (66 .6) 1 ( 3 . 1 )  1 (2 .2)  4 ( 1 0 .8 )  
Phalanges 1 -5 c 9 (25 .7 )  1 5  (33 . 3 )  1 4  (43 .7)  1 7  (37 .7)  29 (78 .3 )  
(Hindl imb) 6- 1 0  c 1 7 (48 . 5 )  0 1 6  (50) 23 (5 1 . 1 )  4 ( l 0.8 )  
> 1 0  3 (8 . 5 )  0 1 (3 . 1 )  4 (8 .8 )  0 ------
a, b, c P< 0.05 when the number of ossified metacarpals and phalanges of the fore and hindlimb of the non-treated fetuses were compared with 





Diabetes i s  a chronic disease. Therefore maternal metabolic complications during 
pregnancy a contributors to fetal growth retardation and malfonnations should be 
considered seriously (Mi l ler, 1 962; Fantel and hepard, 2000) .  Animal models are of 
great value in determining the pathogenetic mechanism of diabetes induced fetal 
malformations. For unl ike in  humans, in  animal models one can effectively control or 
avoid several extraneous variables inherent in human studies. The results of the present 
study have clearly demonstrated that diabetes during pregnancy can lead to several 
maternal compl ications. Additionally diabetes was also found to cause a considerable 
reduction in  fetal weight and an increased incidence of malformations. This study has 
also provided significant evidence for the possible beneficial effects of l ipoic acid 
against fetal malformations in this animal model of diabetes. 
4. 1 Maternal  effect 
Treatment of  pregnant rats with STZ resulted in marked hyperglycemia, polyphagia, 
polydipsia and polyuria. S imilar effects of diabetes have been reported by others 
(Cakatay et aI . ,  2000; Padmanabhan and AI-Zuhair, 1 988;  Padmanabhan and AI-Zuhair, 
1 989) .  Food and water consumption increased progressively and almost doubled during 
the second half of pregnancy possibly because of increasing fetal nutritional needs for 
growth in  the late period of gestation (Figures 4, 5 )  and as a compensatory effort to 
balance the increased water loss due to polyuria and hyperglycemia. These animals also 
fai led to gain in body weight with advancing gestation. This result is consistent with 
those of  other studi es (Eriksson, 1 984; Padmanabhan and Al-Zuhair, 1 988;  
Padmanabhan and AI-Zuhair, 1 989).  Because the mothers starved in plenty, the 
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developing embryos must have been subjected to considerable nutritional deficiencies 
which might explain the fetal growth retardation and congenital anomal ies. Both 
hypoglycemia and hyperglycemia  have been shown to be teratogenic in vitro (Cockroft, 
1 984; adler and Hunter, 1 987) as was maternal starvation in mice in vivo (Mi l ler, 
1 962) .  
The study also attempted to  counter the effect of diabetes by administrating the ideal 
antioxidant LA. Other studies found that 1 00mglkg or 60mg/kg of LA caused 
hypoglycemia that l asted 8 hours after injection in both non-diabetic control and diabetic 
groups of rats (Wiznitzer et a I . ,  1 999; Khamaisi et aI., 1 999).  These studies considered 
only the fasting state but there were no effect on fed state despite the dose of LA. 
However, a 30 mglkg dose of LA had no effect on reducing the blood glucose levels in 
fasting or non fasting animals.  In our study dai ly supplementation with 30 mglkg of 
LA starting on GD 3 and continued through GD 1 9  was found to prevent the 
implantation of embryos completely. Therefore, a lower dose of 20 mg/kg of LA was 
administered starting on GD 6 and continued through GD 1 9 . This delayed dosing 
al lowed sufficient time for the embryos to implant and did not cause significant post­
implantation loss (Table 1 ) . This dosing of LA was also found to lower significantly 
the maternal food and water consumption and moderately promote maternal body weight 
gain in diabetic group of animals comparing with the control groups. 
4.2 Fet a l  effects : 
Under the experimental conditions used in this study, maternal diabetes was not found 
to prevent embryo implantation significantly. Single doses of 20 or 30 mg/kg of LA 
were also not effective in preventing implantat ion in non-diabetic animals. On the other 
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hand, when combined with maternal diabetes 30 mglkg caused complete implantation 
fai lure. It is possible that high doses of LA and diabetic environment act synergistically. 
The exact mechanism by which implantation fai led is not clear from this study. The 
post-implantation loss in the diabetic group was very high (26%) and supplementation 
with LA reduced this incidence to as low as 1 0°'0 . Considering the antioxidant properties 
of LA, the preventative effect of LA on resorption indicates that norn1al process of 
embryo survi al depends on the avai labi l i ty of free radical scavengers. Both in the 
present study and studies reported earlier by other investigators indicate that in  
experimental animals i ntrauterine growth retardation (IUGR) i s  common in STZ-induced 
maternal d iabetes (Eriksson et aI . ,  1 99 1 ;  Padmanabhan and Shafiul l ah,  200 1 ). We 
determined IUGR as reduction in fetal body weight. Al l  those fetuses that weighed 
- 1 SD or -2SD of the control mean fetal weight were regarded as growth retarded. In the 
absence o f  other parameters such as total DNA or total protein content of the embryos, 
body weight could be an effective indicator of fetal growth status (Wilson, 1 973) .  It i s  
not clear from th is  study whether or  not thi s  condition is  a permanent one or  reversible. 
This w i l l  h ave to be tested by al lowing the diabetic animals to complete gestation and 
fol low the growth of  the offspring post-natal ly. Whereas the embryos of  diabetic rodents 
are consistently growth retarded, the offspring of human diabetic mothers are often 
found to b e  macrocosmic.  It has been well established that fetal growth is controlled by 
genetic factors and modulated by several environmental factors with l ifetime 
consequences (Holesman et aI., 1 998). In addition to several growth factors produced by 
the embryo, maternal hormonal and nutritional factors have been implicated in the 
normal process of growth (Seckel, 1 998;  Holesman et ai . ,  1 998) .  Maternal diabetes is  a 
compl icated metabolic d isorder. Therefore this disease by itse lf  may directly impact on 
the fetal growth and development. The fetal macrosomia observed i n  human diabetic 
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pregnancy is  explained in tenns of hyperglycemia-hyperinsul inemia theory proposed by 
Pederson ( 1 954) .  According to this theory, maternal hyperglycemia leads to increased 
insulin production by the fetal pancreas. The excess fetal insul in tends to promote 
excessive glucose and amino acid use by ti ssues and organs, which are sensi tive to 
insu hn, thus result ing in fetal macrosomia. Maternal diabetes has been reported to 
decrease glucose transport into the blastocyst (Moley, 1 999). This  might result III 
absence of  adequate energy and lead to post-implantation embryo loss as observed in  
this study. Additionally d iabetes has been reported to cause apoptosis and reduction in  
cel l number thus contributing to developmental disorders such as malfonnations, growth 
retardation, or fetal death. It is important to point out here that even in human pregnancy 
when diabetes is poorly contro lled fetal growth retardation does occur (Neiger, 1 992).  
Pederson and Molsted-Pederson ( 1 979, 1 98 1 )  have shown that fetuses that eventually 
attain nOIDlal size at birth are also growth retarded early i n  diabetic pregnancy. This can 
be easi ly observed by ultrasonography. The longer gestational period of human 
pregnancy might al low sufficient time for the growth retarded fetuses to catch up unl ike 
rat pregnancy of  a very short duration. This might explain why our rat embryos of 
diabetic group were consistent ly growth retarded. Al l  the growth retarded fetuses had 
hypoplastic skeleton. 
4.3 Skeletal defects:  
Skeletal defects were examined by using the double stain method of Inouye, ( 1 976) in 
which the ossified bones and cart i lages can be clearly observed. The bone appears 
magenta red (alizarin red) i n  color whi le the cartilage b lue (alcian blue). The enti re 
skeleton was examined. 
Hypoplasia affected virtual ly all parts of skeletal system in a large number of fetuses of 
d iabetic group. The large fontanel les and wide sutures of the vault of the skull observed 
in the d iabetic group fetuses indicate a slow rate of growth of the skull and possibly of 
the underlying brain .  everal of the bones of the skull base such as the ethmoid, the 
presphenoid, basispheno id, basioccipi tal and exoccipital were both hypoplastic and 
positioned close to each other. They were poorly ossi fied. The presence of prominent 
non-oss ified cart i lages in the basi cranium of the diabetic group fetuses indicate a delay 
in the normal process of endochondral ossification. The s low ossification rate had 
resulted in  severe reduction in the anteroposterior and transverse diameters of the skul l  
base. These reductions coupled with persistent fontanel les indicate a reduction in  cranial 
capacity. This is the skeletal basis of the microcephaly condition observed grossly in the 
fetuses of the diabetic group. The facial bones such as the mandible, maxi l la, zygoma, 
and the nasal bones were also hypoplastic. The mandible was severely affected resulting 
in  micrognathia. The mandible develops by intramembranous ossification from the 
mesenchyme of the mandibular arch (Kaufman and Bard, 1 999). The Meckel's carti lage 
around which this ossification occurs subsequently disappears. Its remnant is only seen 
at the synphysis menti in ful l  term rat fetuses. In fetuses of the diabetic group, the 
Meckel's cart i lage was persistent in a significant number of fetuses. The hyoid bone 
develops partly form the second and partly from the third pharyngeal arch mesenchyme 
(Kaufman and B ard, 1 999). It has now been wel l  establ ished that the bones of the skul l  
are l argely derived from the neural crest (Figure 22) .  The crest cells originate i n  the 
neuroepithelium and migrate between the surface ectoderm and the neural tube. They 
subsequently pro l i ferate and transform into mesenchymal cells, which constitute the 
pharyngeal arches and the primordium of the skull base (Kaufman and Bard, 1 999). 
These t i ssues were found to develop poorly in our diabetic group fetuses. This  i ndicates 
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Figu re 2 2 :  Derivatives of the neural crest. The crest cel l s  originate during 
neurulation from the dorsolateral edges of the neural folds, migrate peripherally and 
give rise to diverse tissues some of which are indicated here . 
that the neural crest is very sensitive to a maternal diabetic environment. The crest cells 
have been reported to have a low concentration of antioxidants. Diabetes has been 
reported to considerably lower the antioxidant capacity of the pregnant animals (Siman 
et a I . ,  2000) .  Exogenous vi tamin E, a potent antioxidant was found to al leviate diabetes 
related fetal anomal ie . In the present experiment, maternal supp lementation with LA 
was found to have signi ficant beneficial effect in terms of reduction in the frequency of 
hypoplasia of d ifferent skull bones. This observation is  in good agreement with S iman 
et a1. 's (2000) observations in their rat model .  The major difference between their study 
and ours is that in our study the hypoplasia was quite remarkable and reproducible, 
consistent i n  frequency. We have also demonstrated c learly the skeletal bases of facial 
hypoplas ia .  Additional ly the present study has revealed the occurrence of  neural tube 
malformations such as exencephaly and holoprosencephaly. Neural tube defects have 
been reported to occur on human diabetic pregnancy. The animal models of diabetic 
pregnancy however have not successfully reproduced neural tube malformations 
convincingly. The few studies that claimed to have seen neural tube defects have not 
shown sufficient evidence in support of their claim (Wizntzer et aI . ,  1 999). A lso 
important to point out here are the result of experimental hyperglycemia  on embryos 
grown in culture (Sadler, 1 980) in which embryos were cultured in the serum of the 
diabetic mothers. In the present experiments there was a single case of exencephaly in  
the d iabetic group and one case of holoprosencephaly in the STZ+LA group. This 
indicates that although LA is a powerful antioxidant, i t  could reduce the frequency of 
several non-neural organ malformations but not effective in preventing the neural tube 
abnormali ti es in this animal model. In these diabetic animal models, not al l  the fetal 
organs were malformed. Also noteworthy is that not a l l  the embryos of the diabetic 
mothers were found to be mal formed. The lack of organ speci ficity in response to 
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maternal hyperglycemia, and the inter-fetal variation in response to maternal diabetes in 
terms of malformations is difficult to explain. The inter-fetal variation possibly reflects 
the di fferences in genetic makeup of the embryos. The lack of organ specificity in terms 
of their susceptibil ity to mal formation is possibly related to the differential antioxidant 
con entrat ion of  the organ premordium or the di fferential production of react ive oxygen 
species in those premordia. We have only used one antioxidant namely LA. It is 
possible that not al l  the oxygen free radicals could be neutral ized by LA. Different 
malformations fol low different pathogenetic mechanism (Wil lson, 1 973) .  The results of 
this study indicate that only a few of these mechanisms possibly involve the release of 
reactive oxygen species susceptible to LA. 
In keeping with the severe growth retardation, the vertebral columns of fetuses of the 
diabetic group were found to be hypoplastic. Both the cervical and the lurnbosaccaral 
segments had hypopl astic vertebral centra. In a few cases the vertebral centra were 
found to be non-fused. Whereas non-fusion indicates that this was an abnormality 
occurring s lightly later in time during development, the general i zed hypoplasia and 
agenesis indicate an early onset of  abnormal mesenchymal assembly. The rat vertebra is 
derived from mesenchyme of  adjacent somite pairs. These mesenchymal cells assemble 
around the notochord and organize themselves into the vertebral centra. Thus, each 
vertebra has a precarti lagenous (mesenchymal) stage of development. During the 
cart i lagenous phase, two carti lage centers appear in each centrum and fuse together. 
These cart i lagenous bodies go through an endochondral process of ossification and form 
the bony vertebral bodies. The skeleton of the diabetic group embryos were subj ected to 
an altered metabolic environment from very early stages of their development. It is not 
c lear from this study whether there is a particular susceptible period during which the 
skeletal system i s  vulnerable to a diabetic environment. I t  is however clear that the onset 
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of  vertebral mal fonnations occurred in the diabetic group at a very early stage and 
affected different processes of development of the vertebrae. It has been shown that Hox 
genes are involved in mesenchymal speci fication of the axial skeleton (Kessel and 
Gruss 1 99 1 ; Kessel ,  1 992) .  These vertebral malforn1ations observed in the present 
stud did not constitute a pattern . Di fferent embryos appeared to be suscept ible to 
d i fferent degrees. Yet others appeared to be quite resistant. I t  is now clear that even i f  
one asswnes that all the embryos were o f  the same genetic composition, they were al l  
not exposed the same degree of severity of maternal diabetes. This is possibly the reason 
why there was a significant inter-embryo and inter- l i tter variabi l i ty in tenns of the 
number and type of vertebral malfonnations. This indicates that malfonnations 
associated with maternal diabetes are of multi factorial origin in this rat model .  It is also 
c lear from this study why the rescue effect of LA differed in different embryos. 
Both in  the buffer-treated and the LA-treated groups, there was a low frequency of 
hypoplas ia, malpositioning, agenesis and incomplete fusion of sternebrae. The maternal 
diabetic conditions significantly enhanced the incidence of these anomalies. LA 
supplementation partia l ly rescued the embryos from these anomalies. However LA 
treatment did not completely nonnalize the number, size and shape alterations of the 
sternebrae characteristic of the diabetic group. This lack of complete response of the 
sternebrae to LA supplementation indicates that not all of the sternal malfonnations had 
a reactive oxygen species mechanism. 
Like the l urnbosaccral vertebrae, the i li um, ischium and pubis parts of the hip bone and 
the long bones of  the hindl imb namely the femur, tibia and fibula were found to be 
hypop last ic in about 90% of the fetuses of the diabetic group. Lumbosaccaral dysplasia 
3 1  
and dysplasia of  prox imal lower l imb are often reported to occur in infants of diabetic 
mothers (Lenz and Passarge, 1 965) .  That similar anomal ies are observed in diabetic rat 
model shows that the STZ model i s  a good tool to study the pathogenetic mechanisms of 
matemal diabetes-induced fetal anomal ies. It is interesting to note here that LA was 
particu larly effecti e in reducing these anomalies from about 900 0 to as low as 50% 













Maternal diabetes condition resulted in high incidence of fetal resorption, congenital 
mal formations and growth retardation.  Most of the mal forn1at ions involved the cranial 
region of the embryos which shows the high sensi t iv i ty of the craniofac ial precursor cel ls 
(neural crest) in a diabetic envi ronment. Our data also support the hypothesi s  that reactive 
oxygen species are causal ly related to fetal maldevelopment and growth retardation 
associated with maternal diabetes in the rat. In this study, supplementation of the diabetic 
animals with the ideal antioxidant LA was found to have beneficial effects on both maternal­
fetal pair. Lipoic acid was found to improve water and food consumption and maternal body 
weigh gain of the diabetic animals but there was no effect on maternal blood glucose levels. 
The beneficial effects of LA included a significant reduction in resorption/fetal death, 
congenital malformations and growth retardation of the diabetic group. Lipoic acid was seen 
to signi ficantly improve the ossification and growth of the skeletal elements, especially the 
cranial bones. Another original finding of the experiment is that diabetes severely retarded 
the supra-occipital bone developments and caused persistence of Meckel's cartilages. The 
most remarkable enhancement effect of LA was found in the advancement of supra-occipital 
bone development, and regression of  the Meckel's carti lage. It can be concluded that LA 
exerts a protective effect on the embryos of the diabetic rats and so it is a potential 
antiteratogen. 
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RECOM M EN DATION 
Further in vivo studies are warranted to determine the concentrations of different free radicals 
in the maternal ,  fetal and placental compartments of the diabetic pregnancy and try to 
correlate \\ ith fetal outcome in terms of fetal growth retardat ion and malformations. Since 
this study indicated that only certain of the anomal ies were prevented by LA, it appears 
important to consider supplementing combinations of antioxidants such as antiteratogens in 
this model of d iabetes. 
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